@article{8c0a3b9abc73432393b56eb16048cf97,
title = "Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders.",
author = "Grace Levy-Clarke and Jabs, \{Douglas A.\} and Read, \{Russell W.\} and Rosenbaum, \{James T.\} and Albert Vitale and \{Van Gelder\}, \{Russell N.\}",
note = "Topic To provide recommendations for the use of anti-tumor necrosis factor α (TNF-α) biologic agents in patients with ocular inflammatory disorders. Clinical Relevance Ocular inflammatory diseases remain a leading cause of vision loss worldwide. Anti-TNF-α agents are used widely in treatment of rheumatologic diseases.",
year = "2014",
month = mar,
day = "1",
doi = "10.1016/J.OPHTHA.2013.09.048",
language = "American English",
volume = "121",
journal = "Ophthalmology",
number = "3",
}